{"schema_version":"secwatch.filing_event.v1","accession":"0001006837-25-000005","form_type":"8-K","ticker":"VATE","cik":"0001006837","company_name":"INNOVATE Corp.","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.676402+00:00","generated_at":"2026-05-26T04:18:09.058448+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MediBeacon's Transdermal GFR Monitor and Sensor approved by China NMPA; Lumitrace under review","bullets":["China NMPA approved MediBeacon TGFR Monitor and Sensor for kidney function assessment; Lumitrace injection still under review, target approval late 2025.","FDA approved the TGFR system on Jan 17, 2025; MediBeacon developing next-gen TGFR with updated software.","Published studies: eGFR misclassified 35% of CKD patients; transdermal GFR showed r²=0.90 correlation with plasma mGFR across skin types.","MediBeacon CEO highlighted partnership with Huadong Medicine for China rollout of the TGFR system."],"urls":{"canonical":"https://secwatch.observer/filing/0001006837-25-000005","json":"https://secwatch.observer/filing/0001006837-25-000005.json","markdown":"https://secwatch.observer/filing/0001006837-25-000005.md","text":"https://secwatch.observer/filing/0001006837-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006837/000100683725000005/0001006837-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006837/000100683725000005/hchc-20250225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T04:18:09.058448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}